Marta Calatroni

Adverse events linked with the use of chimeric and humanized anti‐CD20 antibodies in children with idiopathic nephrotic syndrome

Alice Bonanni, Marta Calatroni, Matteo D’Alessandro et al. · British Journal of Clinical Pharmacology · 2018 · 57 citations · Full text

Medicine, Immunology, Pediatrics +16

Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival

Giulia Porata, Francesca Raffiotta, Silvana Quaglini et al. · Kidney360 · 2021 · 49 citations · Full text

Medicine, Nephrology, Pathology +17

Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood

Marta Calatroni, Filippo Consonni, Marco Allinovi et al. · Clinical Journal of the American Society of Nephrology · 2021 · 42 citations · Full text

Medicine, Pathology, Pediatrics +9

Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome

Giorgio Trivioli, Seerapani Gopaluni, Maria Letizia Urban et al. · Clinical Kidney Journal · 2020 · 32 citations · Full text

Medicine, Internal Medicine, Nephrology +17

Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis

Mariele Gatto, F Radice, Francesca Saccon et al. · Lupus Science & Medicine · 2022 · 27 citations · Full text

Medicine, Nephrology, Pathology +14